Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease

Journal of the American Geriatrics Society

Volumn 62, Issue 4, 2014, Pages 679-684

  Julayanont, Parunyou ^a,b   Brousseau, Mélanie ^a   Chertkow, Howard ^c,d,e   Phillips, Natalie ^c,f   Nasreddine, Ziad S ^a,d  

^a Center for Diagnosis and Research on Alzheimer's Disease   (Canada)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f Dept of Electrical and Computer Engineering   (Canada)

Author keywords

Alzheimer; Memory Index Score; mild cognitive impairment; Montreal Cognitive Assessment

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; ATTENTION; DISEASE COURSE; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; MALE; MEMORY; MILD COGNITIVE IMPAIRMENT; MONTREAL COGNITIVE ASSESSMENT MEMORY INDEX SCORE; NEUROPSYCHOLOGICAL TEST; ORIENTATION; PROGNOSIS; RETROSPECTIVE STUDY; VERY ELDERLY;

ALZHEIMER; MEMORY INDEX SCORE; MILD COGNITIVE IMPAIRMENT; MONTREAL COGNITIVE ASSESSMENT;

AGED; ALZHEIMER DISEASE; COGNITION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GERIATRIC ASSESSMENT; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; QUEBEC; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84898793286     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12742     Document Type: Article

References (37)

1. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999; 56: 303-308.
2. Matthews FE, Stephan BCM, McKeith IG, et al. Two-year progression from mild cognitive impairment to dementia: To what extent do different definitions agree? J Am Geriatr Soc 2008; 56: 1424-1433.
3. Maioli F, Coveri M, Pagni P, et al. Conversion of mild cognitive impairment to dementia in elderly subjects: A preliminary study in a memory and cognitive disorder unit. Arch Gerontol Geriatr 2007; 44 (Suppl 1): 233-241.
4. Dierckx E, Engelborghs S, De Raedt R, et al. Verbal cued recall as a predictor of conversion to Alzheimer's disease in mild cognitive impairment. Int J Geriatr Psychiatry 2009; 24: 1094-1100.
5. Marcos A, Gil P, Barabash A, et al. Neuropsychological markers of progression from mild cognitive impairment to Alzheimer's disease. Am J Alzheimers Dis Other Demen 2006; 21: 189-196.
6. Devanand DP, Bansal R, Liu J, et al. MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease. Neuroimage 2012; 60: 1622-1629.
7. Devanand DP, Van Heertum RL, Kegeles LS, et al. (99 m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease. Am J Geriatr Psychiatry 2010; 18: 959-972.
8. Devanand DP, Pradhaban G, Liu X, et al. Hippocampal and entorhinal atrophy in mild cognitive impairment: Prediction of Alzheimer disease. Neurology 2007; 68: 828-836.
9. Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 1995; 273: 1274-1278.
10. Papaliagkas VT, Anogianakis G, Tsolaki MN, et al. Prediction of conversion from mild cognitive impairment to Alzheimer's disease by CSF cytochrome c levels and N200 latency. Curr Alzheimer Res 2009; 6: 279-284.
11. Lanari A, Parnetti L,. Cerebrospinal fluid biomarkers and prediction of conversion in patients with mild cognitive impairment: 4-year follow-up in a routine clinical setting. ScientificWorldJournal 2009; 9: 961-966.
12. Devanand DP, Liu X, Tabert MH, et al. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol Psychiatry 2008; 64: 871-879.
13. Davatzikos C, Bhatt P, Shaw LM, et al. Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiol Aging 2011; 32: 2322 e19- e27.
14. Vemuri P, Wiste HJ, Weigand SD, et al. MRI and CSF biomarkers in normal, MCI, and AD subjects: Predicting future clinical change. Neurology 2009; 73: 294-301.
15. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695-699.
16. Aggarwal NT, Wilson RS, Beck TL, et al. Mild cognitive impairment in different functional domains and incident Alzheimer's disease. J Neurol Neurosurg Psychiatry 2005; 76: 1479-1484.
17. Traykov L, Rigaud A-S, Cesaro P, et al. Neuropsychological impairment in the early Alzheimer's disease. Encéphale 2007; 33 (3 Pt 1): 310-316.
18. Grober E, Hall CB, Lipton RB, et al. Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease. J Int Neuropsychol Soc 2008; 14: 266-278.
19. Clément F, Belleville S, Mellah S,. Functional neuroanatomy of the encoding and retrieval processes of verbal episodic memory in MCI. Cortex 2010; 46: 1005-1015.
20. Dannhauser TM, Shergill SS, Stevens T, et al. An fMRI study of verbal episodic memory encoding in amnestic mild cognitive impairment. Cortex 2008; 44: 869-880.
21. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
22. Petersen RC,. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 183-194.
23. Arnáiz E, Almkvist O, Ivnik RJ, et al. Mild cognitive impairment: A cross-national comparison. J Neurol Neurosurg Psychiatry 2004; 75: 1275-1280.
24. Tabert MH, Manly JJ, Liu X, et al. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry 2006; 63: 916-924.
25. Wang PN, Lirng JF, Lin KN, et al. Prediction of Alzheimer's disease in mild cognitive impairment: A prospective study in Taiwan. Neurobiol Aging 2006; 27: 1797-1806.
26. Molinuevo JL, Gõmez-Anson B, Monte GC, et al. Neuropsychological profile of prodromal Alzheimer's disease (Prd-AD) and their radiological correlates. Arch Gerontol Geriatr 2011; 52: 190-196.
27. Rozzini L, Chilovi BV, Conti M, et al. Conversion of amnestic mild cognitive impairment to dementia of Alzheimer type is independent to memory deterioration. Int J Geriatr Psychiatry 2007; 22: 1217-1222.
28. Wilson RS, Leurgans SE, Boyle PA, et al. Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment. Arch Neurol 2011; 68: 351-356.
29. Petersen RC, Roberts RO, Knopman DS, et al. Mild cognitive impairment: Ten years later. Arch Neurol 2009; 66: 1447-1455.
30. Johns EK, Phillips NA, Belleville S, et al. The profile of executive functioning in amnestic mild cognitive impairment: Disproportionate deficits in inhibitory control. J Int Neuropsychol Soc 2012; 18: 541-555.
31. Mickes L, Wixted JT, Fennema-Notestine C, et al. Progressive impairment on neuropsychological tasks in a longitudinal study of preclinical Alzheimer's disease. Neuropsychology 2007; 21: 696-705.
32. Miettinen PS, Pihlajamäki M, Jauhiainen AM, et al. Structure and function of medial temporal and posteromedial cortices in early Alzheimer's disease. Eur J Neurosci 2011; 34: 320-330.
33. Rami L, Solé-Padullés C, Fortea J, et al. Applying the new research diagnostic criteria: MRI findings and neuropsychological correlations of prodromal AD. Int J Geriatr Psychiatry 2012; 27: 127-134.
34. Kawas CH,. Clinical practice. Early Alzheimer's disease. N Engl J Med 2003; 349: 1056-1063.
35. Hort J, O'Brien JT, Gainotti G, et al. EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol 2010; 17: 1236-1248.
36. Chertkow H, Massoud F, Nasreddine Z, et al. Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment, without dementia. CMAJ 2008; 178: 1273-1285.
37. Weimer DL, Sager MA,. Early identification and treatment of Alzheimer's disease: Social and fiscal outcomes. Alzheimers Dement 2009; 5: 215-226.